Predictive Risk Factors for Clinically Related Pancreatic Fistula After Pancreaticoduodenectomy: Analysis of 248 Patients
Abstract views: 240 / PDF downloads: 261
DOI:
https://doi.org/10.58600/eurjther1610Keywords:
pancreaticoduodenectomy, pancreatic fistula, predictive, risk factorAbstract
Objective:Postoperative pancreatic fistula (POPF) affects 13-50% of patients undergoing pancreaticoduodenectomy (PD), and remains the main source of post-PD morbidity and mortality. Therefore, determining predictive risk factors for POPF remains popular today. This study aimed to determine the predictive risk factors for clinically related postoperative pancreatic fistula (CR-POPF) in the preoperative and early postoperative period in patients that underwent PD.
Methods: This is a retrospective study involving 248 patients who underwent PD between January 2015 and December 2019 in our center. We compared the groups that did and did not develop CR-POPF. We determined the risk factors affecting CR-POPF by stepwise logistic regression analysis.
Results:141 (56.8%) of the patients included in the study were male, and the median age was 63 (56-70)/year. The CR-POPF rate was 18.1%. We found a statistically significant difference (p <0.05) in the following parameters: diabetes, smoking, preoperative leukocyte, preoperative neutrophil, postoperative first day (POD1) amylase, POD1 AST, POD1 ALT, POD1 CRP, POD1 lymphocyte-CRP ratio (LCR), postoperative third day (POD3) lymphocyte, POD3 CRP, in POD3 neutrophil-lymphocyte ratio, POD3 platelet-lymphocyte ratio (PLR), POD3 AST-ALT ratio, POD3 LCR, surgeon experience, incision type, Wirsung diameter, pancreatic tissue and operation time. In the stepwise logistic regression model, we found POD1 AST, POD3 CRP, POD3 TLR, diabetes, surgeon experience, and Wirsung diameter as predictive risk factors.
Conclusions: Despite some new methods to reduce the occurrence of POPF, the expected improvement in POPF rates is elusive. Predictive risk factors for POPF may also vary because the response of patients to trauma varies and the postoperative period is very dynamic. In our study, we found POD1 AST, POD3 CRP, POD3 TLR, diabetes, surgeon experience and Wirsung diameter as predictive risk factors for CR-POPF.
Metrics
References
Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin. 70(1):7-30. https://doi.org/10.3322/caac.21590
Bassi C, Marchegiani G, Dervenis C, et al. (2017) The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery. 161(3):584-591. https://doi.org/10.1016/j.surg.2016.11.014
Iacono C, Verlato G, Ruzzenente A, et al. (2013) Systematic review of central pancreatectomy and meta-analysis of central versus distal pancreatectomy. Br J Surg. 100(7):873-885. https://doi.org/10.1002/bjs.9136
Berger AC, Howard TJ, Kennedy EP, et al. (2009) Does type of pancreaticojejunostomy after pancreaticoduodenectomy decrease rate of pancreatic fistula? A randomized, prospective, dual-institution trial. J Am Coll Surg. 208(5):738-749. https://doi.org/10.1016/j.jamcollsurg.2008.12.031
Pedrazzoli S (2017) Pancreatoduodenectomy (PD) and postoperative pancreatic fistula (POPF): A systematic review and analysis of the POPF-related mortality rate in 60,739 patients retrieved from the English literature published between 1990 and 2015. Medicine (Baltimore). 96(19):e6858. https://doi.org/10.1097/MD.0000000000006858
Bassi C, Dervenis C, Butturini G, et al. (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 138(1):8-13. https://doi.org/10.1016/j.surg.2005.05.001
Chen BP, Bennett S, Bertens KA, Balaa FK, Martel G (2018) Use and acceptance of the International Study Group for Pancreatic Fistula (ISGPF) definition and criteria in the surgical literature. HPB (Oxford). 20(1):69-75. https://doi.org/10.1016/j.hpb.2017.08.022
Kawaida H, Kono H, Hosomura N, et al. (2019) Surgical techniques and postoperative management to prevent postoperative pancreatic fistula after pancreatic surgery. World J Gastroenterol. 25(28):3722-3737. https://doi.org/10.3748/wjg.v25.i28.3722
De Schryver N, Wittebole X, Hubert C, Gigot JF, Laterre PF, Castanares-Zapatero D (2015) Early hyperlactatemia predicts pancreatic fistula after surgery. BMC Anesthesiol. 15:109. https://doi.org/10.1186/s12871-015-0093-x
Hu BY, Wan T, Zhang WZ, Dong JH (2016) Risk factors for postoperative pancreatic fistula: Analysis of 539 successive cases of pancreaticoduodenectomy. World J Gastroenterol. 22(34):7797-7805. https://doi.org/10.3748/wjg.v22.i34.7797
Addeo P, Delpero JR, Paye F, et al. (2014) Pancreatic fistula after a pancreaticoduodenectomy for ductal adenocarcinoma and its association with morbidity: a multicentre study of the French Surgical Association. HPB (Oxford). 16(1):46-55. https://doi.org/10.1111/hpb.12063
Srivastava S, Sikora SS, Pandey CM, Kumar A, Saxena R, Kapoor VK (2001) Determinants of pancreaticoenteric anastomotic leak following pancreaticoduodenectomy. ANZ J Surg. 71(9):511-515. https://doi.org/10.1046/j.1440-1622.2001.02184.x
Cheng Q, Zhang B, Zhang Y, et al. (2007) Predictive factors for complications after pancreaticoduodenectomy. J Surg Res. 139(1):22-29. https://doi.org/10.1016/j.jss.2006.07.028
Søreide K, Healey AJ, Mole DJ, Parks RW (2019) Pre-, peri- and post-operative factors for the development of pancreatic fistula after pancreatic surgery. HPB (Oxford). 21(12):1621-1631. https://doi.org/10.1016/j.hpb.2019.06.004
Schmidt CM, Turrini O, Parikh P, et al. (2010) Effect of hospital volume, surgeon experience, and surgeon volume on patient outcomes after pancreaticoduodenectomy: a single-institution experience. Arch Surg. 145(7):634-640. https://doi.org/10.1001/archsurg.2010.118
Nahm CB, Connor SJ, Samra JS, Mittal A (2018) Postoperative pancreatic fistula: a review of traditional and emerging concepts. Clin Exp Gastroenterol. 11:105-118. https://doi.org/10.2147/CEG.S120217
Ven Fong Z, Correa-Gallego C, Ferrone CR, et al. (2015) Early Drain Removal--The Middle Ground Between the Drain Versus No Drain Debate in Patients Undergoing Pancreaticoduodenectomy: A Prospective Validation Study. Ann Surg. 262(2):378-383. https://doi.org/10.1097/SLA.0000000000001038
Eshmuminov D, Schneider MA, Tschuor C, et al. (2018) Systematic review and meta-analysis of postoperative pancreatic fistula rates using the updated 2016 International Study Group Pancreatic Fistula definition in patients undergoing pancreatic resection with soft and hard pancreatic texture. HPB (Oxford). 20(11):992-1003. https://doi.org/10.1016/j.hpb.2018.04.003
Liu QY, Zhang WZ, Xia HT, et al. (2014) Analysis of risk factors for postoperative pancreatic fistula following pancreaticoduodenectomy. World J Gastroenterol. 20(46):17491-17497. https://doi.org/10.3748/wjg.v20.i46.17491
Su AP, Zhang Y, Ke NW, et al. (2014) Triple-layer duct-to-mucosa pancreaticojejunostomy with resection of jejunal serosa decreased pancreatic fistula after pancreaticoduodenectomy. J Surg Res. 186(1):184-191. https://doi.org/10.1016/j.jss.2013.08.029
Ansorge C, Strömmer L, Andrén-Sandberg Å, Lundell L, Herrington MK, Segersvärd R (2012) Structured intraoperative assessment of pancreatic gland characteristics in predicting complications after pancreaticoduodenectomy. Br J Surg. 99(8):1076-1082. https://doi.org/10.1002/bjs.8784
Welsch T, Frommhold K, Hinz U, et al. (2008) Persisting elevation of C-reactive protein after pancreatic resections can indicate developing inflammatory complications. Surgery. 143(1):20-28. https://doi.org/10.1016/j.surg.2007.06.010
Solaini L, Atmaja BT, Watt J, et al. (2015) Limited utility of inflammatory markers in the early detection of postoperative inflammatory complications after pancreatic resection: Cohort study and meta-analyses. Int J Surg. 17:41-47. https://doi.org/10.1016/j.ijsu.2015.03.009
Giardino A, Spolverato G, Regi P, et al. (2016) C-Reactive Protein and Procalcitonin as Predictors of Postoperative Inflammatory Complications After Pancreatic Surgery. J Gastrointest Surg. 20(8):1482-1492. https://doi.org/10.1007/s11605-016-3171-6
Partelli S, Pecorelli N, Muffatti F, et al. (2017) Early Postoperative Prediction of Clinically Relevant Pancreatic Fistula after Pancreaticoduodenectomy: usefulness of C-reactive Protein. HPB (Oxford). 19(7):580-586. https://doi.org/10.1016/j.hpb.2017.03.001
Palani Velu LK, McKay CJ, Carter CR, McMillan DC, Jamieson NB, Dickson EJ (2016) Serum amylase and C-reactive protein in risk stratification of pancreas-specific complications after pancreaticoduodenectomy. Br J Surg. 103(5):553-563. https://doi.org/10.1002/bjs.10098
Ansorge C, Nordin JZ, Lundell L, et al. (2014) Diagnostic value of abdominal drainage in individual risk assessment of pancreatic fistula following pancreaticoduodenectomy. Br J Surg. 101(2):100-108. https://doi.org/10.1002/bjs.9362
Sert OZ, Berkesoglu M, Canbaz H, Olmez A, Tasdelen B, Dirlik MM (2021) The factors of pancreatic fistula development in patients who underwent classical pancreaticoduodenectomy. Ann Ital Chir. 92:35-40. PMID: 32529981
Kinaci E, Sevinc MM, Ozakay A, Bayrak S, Cakar E, Sari S (2016) Intraoperative acidosis is a new predictor for postoperative pancreatic fistula after pancreaticoduodenectomy. Hepatobiliary Pancreat Dis Int. 15(3):302-309. https://doi.org/10.1016/s1499-3872(16)60068-1
Liu R, Cai Y, Cai H, et al. (2021) Dynamic prediction for clinically relevant pancreatic fistula: a novel prediction model for laparoscopic pancreaticoduodenectomy. BMC Surg. 21(1):7. https://doi.org/10.1186/s12893-020-00968-5
Winter JM, Cameron JL, Yeo CJ, et al. (2007) Biochemical markers predict morbidity and mortality after pancreaticoduodenectomy. J Am Coll Surg. 204(5):1029-1038. https://doi.org/10.1016/j.jamcollsurg.2007.01.026
Ida M, Tachiiri Y, Sato M, Kawaguchi M (2019) Neutrophil-to-lymphocyte ratio as indicator to severe complication after pancreaticoduodenectomy or distal pancreatectomy. Acta Anaesthesiol Scand. 63(6):739-744. https://doi.org/10.1111/aas.13341
Downloads
Published
How to Cite
License
Copyright (c) 2023 European Journal of Therapeutics
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.